HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bill To Restrict Bulk DXM Sales Reintroduced In House

This article was originally published in The Tan Sheet

Executive Summary

Legislation reintroduced by Reps. Fred Upton, R-Mich., and Rick Larsen, D-Wash., Feb. 8 would restrict online sales of bulk dextromethorphan to entities registered with FDA, but does not propose methods of preventing abuse of OTC cough medicines

You may also be interested in...



“Snurf” Abuse Reports Revive Interest In DXM Bills

A recent report of young people suspected of abusing "Snurf" has reignited interest on Capitol Hill in restricting bulk purchases of raw dextromethorphan and an age restriction on OTCs containing the cough suppressant

House DXM Bill Sponsor Expects Senate To Approve Measure This Year

Michigan Congressman Fred Upton says he expects to see a bill to restrict online sales of bulk dextromethorphan to entities registered with FDA pass this year

First DXM Age Law Passes While Voluntary Restrictions Increase

A New York county adopts an ordinance limiting sales of dextromethorphan products to consumers 19 years old and up, while trade groups are looking to a uniform national solution that will curb abuse, maintain consumer access and limit retailer burdens

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS137898

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel